Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05745285 · ClinicalTrials.gov registry record · NA

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

A NA study of Lymphoma and Leukemia, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
3
Study locations

NCT05745285 is a NA study of Lymphoma and Leukemia that is actively recruiting participants, run by University of Miami. The registered enrollment target is 400 participants, below the 482-participant average among 299 other Lymphoma trials with a reported enrollment target (17% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05745285, a NA study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.

Interventions

  • OTHER LLS Program

Study Locations (3)

Florida

  • Sylvester Comprehensive Cancer Center - Miami

Illinois

  • University of Chicago Comprehensive Cancer Center - Chicago

Texas

  • Mays Cancer Center at UT Health San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-02-04
Est. Completion 2026-11-01
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT05745285

The ClinicalTrials.gov registry entry for NCT05745285 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 299 other Lymphoma trials with a reported enrollment target (17% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which LLS Program is the first listed.

NCT05745285 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT05745285 about?

NCT05745285 is a clinical study titled "Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care". The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.

What is the current status of trial NCT05745285?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-02-04. Estimated completion is 2026-11-01.

What conditions does trial NCT05745285 study?

This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Myeloma.

What interventions are being tested in trial NCT05745285?

The interventions under investigation include: LLS Program (OTHER).

Who is sponsoring clinical trial NCT05745285?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05745285 being conducted?

This trial has 3 study locations across Florida, Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.